B-CELL ALL
Clinical trials for B-CELL ALL explained in plain language.
Never miss a new study
Get alerted when new B-CELL ALL trials appear
Sign up with your email to follow new studies for B-CELL ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Donor immune cells show promise against relapsed blood cancers after transplant
Disease control OngoingThis early-phase study tests a new approach for people with CD19-positive blood cancers (like lymphoma or leukemia) that returned after a stem cell transplant. Researchers take immune cells (T cells) from the original stem cell donor, modify them to better recognize and attack ca…
Matched conditions: B-CELL ALL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Can a simple drug tame CAR-T's dangerous side effects?
Disease control OngoingThis study tests whether the drug anakinra can prevent or reverse severe side effects from CAR-T cell therapy, a powerful cancer treatment. About 62 adults with certain B-cell cancers (like leukemia or lymphoma) will receive anakinra alongside their CAR-T cells. The goal is to re…
Matched conditions: B-CELL ALL
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 07, 2026 18:43 UTC